Search details
1.
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques.
Cell
; 187(1): 79-94.e24, 2024 01 04.
Article
in English
| MEDLINE | ID: mdl-38181743
2.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Cell
; 187(12): 2919-2934.e20, 2024 Jun 06.
Article
in English
| MEDLINE | ID: mdl-38761800
3.
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.
J Virol
; 94(21)2020 10 14.
Article
in English
| MEDLINE | ID: mdl-32817216
4.
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.
J Immunol
; 198(3): 1047-1055, 2017 02 01.
Article
in English
| MEDLINE | ID: mdl-28011932
5.
Conformationally selective RNA aptamers allosterically modulate the ß2-adrenoceptor.
Nat Chem Biol
; 12(9): 709-16, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27398998
6.
TCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeys.
PLoS Pathog
; 10(4): e1004069, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24743648
7.
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk.
Proc Natl Acad Sci U S A
; 110(45): 18220-5, 2013 Nov 05.
Article
in English
| MEDLINE | ID: mdl-24145401
8.
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors.
Proc Natl Acad Sci U S A
; 110(45): 18214-9, 2013 Nov 05.
Article
in English
| MEDLINE | ID: mdl-24145434
9.
HIV-1 antibodies and vaccine antigen selectively interact with lipid domains.
Biochim Biophys Acta
; 1838(10): 2662-9, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25019685
10.
Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
J Virol
; 88(16): 9406-17, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24920809
11.
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion.
J Virol
; 87(3): 1554-68, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23175357
12.
Microsecond dynamics control the HIV-1 Envelope conformation.
Sci Adv
; 10(5): eadj0396, 2024 Feb 02.
Article
in English
| MEDLINE | ID: mdl-38306419
13.
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines.
J Am Chem Soc
; 135(35): 13113-20, 2013 Sep 04.
Article
in English
| MEDLINE | ID: mdl-23915436
14.
Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage.
Nat Commun
; 14(1): 2782, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-37188681
15.
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
bioRxiv
; 2023 Jul 26.
Article
in English
| MEDLINE | ID: mdl-37546738
16.
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies.
bioRxiv
; 2023 Dec 30.
Article
in English
| MEDLINE | ID: mdl-38168268
17.
Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens.
J Virol
; 85(3): 1340-7, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21106741
18.
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.
J Virol
; 85(22): 11725-31, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21917975
19.
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates.
Cell Rep
; 39(13): 111021, 2022 06 28.
Article
in English
| MEDLINE | ID: mdl-35767950
20.
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice.
Sci Transl Med
; 14(629): eabj7125, 2022 Jan 26.
Article
in English
| MEDLINE | ID: mdl-34726473